Our Chief Scientific Officer, Prof. dr. Rob Collin, will be a keynote speaker at the Dutch Antisense Therapeutics Symposium! Prof. Collin will update the audience on the latest science on splicing modulation therapies for inherited retinal diseases. Please follow us for more information in our next post on the keynote lecture!
Related Posts
